Page 759 - Coronavirus Vaccine

Covishield shows 60-70% efficacy; Modi to visit Serum Institute on Saturday

SII is unlikely to announce any interim data from the trials here. It will wait to compile and analyse data, before sharing it with the Indian regulator.

PM to visit Serum Institute in Pune on Nov 28 to review vaccine development

Rao had also informed that ambassadors and envoys from 100 countries will visit the Serum Institute of India and the Gennova Biopharmaceuticals Ltd here on December 4

CEO says AstraZeneca likely to run new global Covid vaccine trial: Report

"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Soriot was quoted as saying

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: SII

Serum Institute of India said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly

Delhi adds 91 Covid-19 fatalities taking the city's death toll to 8,811

The positivity rate was 8.65 per cent. It was 8.49 per cent on Wednesday.

PM Modi to visit Serum Institute of India in Pune on November 28

Serum Institute has partnered with global pharma giant AstraZeneca and the Oxford University

Entire Delhi can be vaccinated in a month: State immunisation officer

Experts said that Delhi has sufficient infrastructure and equipment to effectively cover its entire population.

Thailand to sign Covid-19 vaccine agreement with Oxford-AstraZeneca

The announcement comes as other countries in the region like the Philippines prepare to sign similar deals with AstraZeneca

Top headlines: Questions over Oxford vaccine data, Vedanta under pressure

Modi bats for One Nation One Election, Keki Mistry says NPAs in real estate will inch up , and more top headlines of the day

Phase three trials of Bharat Biotech's covaxin commences in AIIMS

The trial will cover around 28,500 subjects aged 18 years and above

AstraZeneca faces more Covid-19 vaccine questions after manufacturing error

Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one

Covid-19 vaccine rush in China raises fears of booming black market

Inevitable supply shortages fueling concerns about inequitable distribution and even the emergence of illegal markets

AstraZeneca Covid-19 vaccine's 90% efficacy came in younger trial group

The vaccine being developed with Oxford University was 90 per cent effective when a half-dose was given before a full-dose booster, the partners said on Monday

India Coronavirus Dispatch: How do you vaccinate a billion people?

AstraZeneca's manufacturing error, lack of transparency in Indian vaccine trials, should Indian states consider lockdowns again?-news relevant to India's fight against Covid-19

World Coronavirus Dispatch: Growing disquiet over Oxford-Astra vaccine data

Covid passports seen key to resuming travel, Sewage testing may offer early signs of outbreaks, IBM to shed 10,000 jobs in Europe, and other pandemic-related news across the globe

Covid-19 Factoid: India's new cases exceed daily recoveries in last 2 days

Country added over 6,000 new actives cases for two straight days as states report surge.

AstraZeneca manufacturing error clouds coronavirus vaccine study results

AstraZeneca and Oxford University have acknowledged a manufacturing error that is raising questions about preliminary results of their experimental Covid-19 vaccine

Oil rises for 5th day straight on surprise fall in US stocks, vaccine hopes

Brent futures were up 45 cents, or 0.9%, at $49.06 a barrel by 0245 GMT, after rising around 1.6% in the previous session

USA coronavirus deaths top 260,000, says Johns Hopkins University

US Covid-19 deaths surpassed 2,60,000 on Wednesday, according to the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University

Bihar coronavirus update: State reports 763 fresh Covid-19 cases

Bihar's Covid-19 tally rose to 232,459 after 763 new cases were reported in the past 24 hours, while four fresh fatalities took the death toll to 1,237